POU3F4: A Drug Target / Disease Biomarker (G5456)

Target Name: POU3F4

NCBI ID: G5456

POU3F4

POU3F4: A Drug Target / Disease Biomarker

POU3F4, also known as putative outer repeat-containing gene 4, is a gene that has been identified as a potential drug target or biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure, which consists of a repeat of the amino acid Asp at its cytosine residue, makes it a unique candidate for drug targeting.

The POU3F4 gene is located on chromosome 16 and encodes a protein known as POU3F4, which is a key regulator of the cell cycle. The POU3F4 protein plays a crucial role in preventing the cell from entering the G1 phase, which is the stage of cell growth and proliferation. This protein helps to keep the cell in the G0 phase, where it can prepare for cell division, and prevent the cell from getting into a state of apoptosis, which is cell death.

One of the key functions of POU3F4 is its ability to interact with the protein p21, which is a key regulator of the cell cycle. POU3F4 and p21 have been shown to work together to regulate the cell cycle and prevent the cell from getting into the G1 phase. This interaction between POU3F4 and p21 makes POU3F4 a potential drug target or biomarker, as drugs that target this interaction may be able to inhibit the growth and proliferation of cancer cells.

Another potential mechanism by which POU3F4 may be involved in disease is its role in the development of neurodegenerative diseases. The POU3F4 gene has been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. This is because POU3F4 is a key regulator of the cell cycle and is involved in the production of the protein tau, which is a hallmark protein of neurodegenerative diseases.

In addition to its potential role in neurodegenerative diseases, POU3F4 may also be involved in the development of autoimmune disorders. The POU3F4 gene has been shown to be involved in the development of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis. This is because POU3F4 is involved in the production of the protein PD-L1, which is a key regulator of immune responses.

Despite its potential role in a variety of diseases, POU3F4 has not yet been fully studied or characterized. Further research is needed to fully understand the function of POU3F4 and its potential as a drug target or biomarker.

In conclusion, POU3F4 is a unique and promising candidate for drug targeting or biomarker due to its unique structure and its involvement in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand its function and its potential as a drug target or biomarker.

Protein Name: POU Class 3 Homeobox 4

Functions: Probable transcription factor which exert its primary action widely during early neural development and in a very limited set of neurons in the mature brain

The "POU3F4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POU3F4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets